retatrutide clinical trial duration How to Get in 2026 ESC 2024: Retatrutide improves lipid

In December 2025, Nektar Therapeutics reported topline data from its Phase 2b REZOLVE-AA trial evaluating rezpegaldesleukin in patients with severe-to-very-severe AA

When stool remains in the colon longer, it becomes harder and more difficult to pass

If denials are grounded in consistent, evidence-based medical necessity criteria, why do they so often reverse under external scrutiny

M.et al (2005)

The psychosocial risk factors associated with large reductions in weight and weight regain overlap significantly with those linked to perimenopause

The GIP receptor, a class of B G-protein-coupled receptors (GPCRs) that is widely expressed in a variety of tissues, is the binding site that mediates the systemic effects